The research capabilities of the High Throughput Screening (HTS) and Biological Assays Unit at the BCDD include:
Cell culture of multiple cell types modeling disease.
Performance of a diverse range of biological assays adapted for HTS of drugs in 96, 384 or 1536 well plates such as:
Image-based HTS analysis assays
HT QRT-PCR and miRNA microarray assays
HT fluorometry – spectrometry – luminometry assays
HT DNA-RNA-Protein extraction for “omics”